Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Award $2M in FY 2005 for Novel Predictive ADME-Tox Programs

NEW YORK, Nov. 5 (GenomeWeb News) - The National Institutes of Health has set aside $2 million for a request for applications for projects that develop new ways to obtain comprehensive ADME-Tox profiles.

 

The profiles would better predict how new molecular entities will perform in humans in order to reduce the failure rate in clinical testing.

Specifically, the NIH said it intends to commit around $2 million in fiscal year 2005 to fund four to seven new grants that respond to the RFA. Applicants may request a project period of up to four years and a budget for direct costs up to $250,000 per year.

Examples of preclinical ADME-Tox evaluation tools that will be considered for awards include statistical models developed from preclinical and available clinical data; computational models, including data integration tools that link mRNA levels, protein expression levels, protein activities, and metabolite profiles with chemical scaffolds and ADME-Tox parameters; and identifying novel biomarkers to predict ADME-Tox properties of molecular entities and potential drug interactions.

 

Letters of intent are due on Dec. 17, and applications are due on Jan. 21, 2005. Awards are expected to start next September. Further information is available here.

 

The project, "Novel Preclinical Tools for Predictive ADME-Toxicology," is an NIH Roadmap initiative.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.